Construction and immunogenicity in mice of attenuated Salmonella typhi expressing Plasmodium falciparum merozoite surface protein 1 (MSP-1) fused to tetanus toxin fragment C
Shaoguang Wu, Myron M. Levine(University of Maryland, Baltimore), Magda S. Beier, Thames Pickett(Center for Biologics Evaluation and Research), Oscar G. Gómez‐Duarte(University at Buffalo, State University of New York), James E. Galen, Anthony A. Holder(The Francis Crick Institute), Marcelo B. Sztein(University of Maryland, Baltimore)
Cited by 15
Related Papers
Global burden of Shigella infections: implications for vaccine development and implementation of control strategies.
|PubMed|1999|1.3k
Safety and immunogenicity in man of a synthetic peptide malaria vaccine against Plasmodium falciparum sporozoites
|Nature|1987|503
Global analysis of transcript and protein levels across the <i>Plasmodium falciparum</i> life cycle
|Genome Research|2004|457
Serum Levels of the Proinflammatory Cytokines Interleukin-1 Beta (IL-1β), IL-6, IL-8, IL-10, Tumor Necrosis Factor Alpha, and IL-12(p70) in Malian Children with Severe<i>Plasmodium falciparum</i>Malaria and Matched Uncomplicated Malaria or Healthy Controls
|Infection and Immunity|2004|447
Clinical trials of Shigella vaccines: two steps forward and one step back on a long, hard road
|Nature Reviews Microbiology|2007|372